Ventyx Biosciences, Inc. (VTYX)
NASDAQ: VTYX · Real-Time Price · USD
1.070
-0.080 (-6.96%)
At close: Apr 1, 2025, 4:00 PM
1.130
+0.060 (5.63%)
After-hours: Apr 1, 2025, 5:27 PM EDT

Ventyx Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Net Income
-135.12-192.96-108.43-83.75-28.17
Upgrade
Depreciation & Amortization
1.350.940.470.03-
Upgrade
Loss (Gain) From Sale of Assets
0.14----
Upgrade
Asset Writedown & Restructuring Costs
-0.29-21.69-
Upgrade
Loss (Gain) From Sale of Investments
-9.52-9.18-2.23--
Upgrade
Stock-Based Compensation
22.9328.5916.572.730.05
Upgrade
Other Operating Activities
-0.09--16.6321.12
Upgrade
Change in Accounts Payable
-2.64-0.751.612.440.59
Upgrade
Change in Other Net Operating Assets
-7.926.55-6.771.570.22
Upgrade
Operating Cash Flow
-130.87-166.52-98.77-38.65-6.2
Upgrade
Capital Expenditures
-0.24-0.51-0.28-0.26-
Upgrade
Cash Acquisitions
---1.9-
Upgrade
Investment in Securities
-15.27101.45-74.66-216-
Upgrade
Investing Cash Flow
-15.51100.94-74.93-214.37-
Upgrade
Long-Term Debt Issued
---0.456.13
Upgrade
Net Debt Issued (Repaid)
---0.456.13
Upgrade
Issuance of Common Stock
95.5153.33167.77158.880
Upgrade
Financing Cash Flow
122.1253.33167.77323.556.13
Upgrade
Foreign Exchange Rate Adjustments
-0.06-0.01-0.040.01-
Upgrade
Net Cash Flow
-24.32-12.27-5.9770.55-0.07
Upgrade
Free Cash Flow
-131.11-167.04-99.05-38.91-6.2
Upgrade
Free Cash Flow Per Share
-1.92-2.85-1.89-3.03-3.12
Upgrade
Cash Income Tax Paid
----0
Upgrade
Levered Free Cash Flow
-78.46-95.04-58.58-33.09-3.77
Upgrade
Unlevered Free Cash Flow
-78.46-95.04-58.58-33.03-3.55
Upgrade
Change in Net Working Capital
9.72-5.944.64-6.44-0.81
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q